Corpus Intelligence IC Memo — WAKE MED CARY HOSPITAL 2026-04-26 04:06 UTC
IC Memo — WAKE MED CARY HOSPITAL
Investment Committee Memorandum | NC | 189 beds | Grade C | EBITDA uplift $23.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WAKE MED CARY HOSPITAL

CCN 340173 | WAKE, NC | 189 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WAKE MED CARY HOSPITAL is a 189-bed suburban community hospital in WAKE, NC with $318.1M in net patient revenue and a -3.6% operating margin. The hospital serves a payer mix of 26.9% Medicare, 2.3% Medicaid, and 70.7% commercial.

Thesis: Undervalued. Our ML models identify $23.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.6% to 3.7% (+736bps).

Net Revenue HCRIS$318.1M
Current EBITDA COMPUTED$-11.6M
Operating Margin COMPUTED-3.6%
Occupancy HCRIS89.4%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS24.7%
Distress Probability ML37.8%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
50
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -3.6% places it below the state median. Among 50 size-comparable peers (94-378 beds), the median margin is -1.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (94-378), prioritizing same-state peers. 50 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WAKE MED CARY HOSPITAL (Target)NC189$318.1M-3.6%
DUKE RALEIGH HOSPITALNC186$683.0M3.7%
ATRIUM HEALTH PINEVILLENC365$575.1M25.8%
CATAWBA VALLEY MEDICAL CENTERNC200$451.9M5.9%
DUKE REGIONAL HOSPITALNC301$421.0M-19.8%
HIGH POINT MEDICAL CENTERNC288$406.1M0.3%
CAROLINAEAST MEDICAL CENTERNC312$365.1M-2.9%
MARGARET R. PARDEE MEMORIAL HONC160$341.3M-5.7%
JOHNSTON HEALTHNC179$331.7M9.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $23.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.7M+210bp18mo
Cost to Collect4.5%2.5%$6.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.9M+122bp9mo
Clean Claim Rate88.0%96.0%$204K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.7M
Cost to Collect
$6.4M
Denial Rate Reduction
$6.3M
A/R Days Reduction
$3.9M
Clean Claim Rate
$204K
Total EBITDA Uplift$23.4M
Current EBITDA$-11.6M
+ RCM Uplift+$23.4M
Pro Forma EBITDA$11.8M
Current Margin-3.6%
Pro Forma Margin3.7%
WC Released (1x)$12.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-17.9M$157.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-17.9M$167.6M0.00x-100.0%
Bull Case9.0x11.0x$-16.1M$239.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-16.1M$256.1M0.00x-100.0%
Bear Case11.0x10.0x$-19.6M$46.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-19.6M$44.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 50 hospitals with 94-378 beds
  • Same-state prioritization (n=51)
  • Comp margins: P25=-8.0% / P50=-1.1% / P75=8.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.